Overview
- The lay-judge trial in Mito concluded on June 18 with prosecutors asking for life imprisonment for Akama Megumi, who denies the charges.
- Akama is accused of injecting air into intravenous lines to kill two elderly residents at the Keyaki no Ie facility in 2020.
- The prosecution relies on circumstantial evidence and colleague witness accounts, including testimony that the defendant entered one victim’s room just before a sudden collapse and that a syringe was moved near the other victim.
- The defense argues the deaths may be natural and points to forensic and procedural gaps, noting one body was not given a judicial autopsy and that the amount of gas found in blood vessels was small.
- The July 7 ruling will determine guilt in a case that raises questions about care-facility oversight, how air-embolism deaths are forensically proven, and protections for vulnerable residents.